Case Study
Pre-launch exploratory research in rare disease (Hemophilia A: HA)
Objective of the Study
Evaluate the potential and positioning of a new product X indicated for Hemophilia A.
Methodology
GEOGRAPHICAL SCOPE: France
METHODOLOGY:
Three-phase approach:
-Operational desk research.
-Online workshop
-Qualitative and Quantitative interviews
TARGET DETAILS:
HCPs treating patients with HA
LOI:
LOI = 120 minutes for the online Workshop
LOI = 20 minutes for Qualitative and Quantitative interviews
MAIN RESULTS
HA market assessment:
Provided an overview of how HA is perceived and treated (for the following indications: prophylaxis, on demand, with and without inhibitors)
For each indication, described the current algorithm: (1)Identified how current treatments are perceived, (2)drivers and barriers of prescription, (3)how each treatment differentiated itself from the others and (4)patient profile eligible for each treatment.
Potential of a new product X for HA:
Evaluated the new offer : Strengths, weaknesses and how it differentiates itself from the current treatments.
Identified and quantified patient profiles eligible and non-eligible for the new product X.
Estimated future market share of the new product X.
KEY TAKE-AWAY
Analysed the current market context to highlight the position of the client’s treatment and explored future growth opportunities.
Provided actionable recommendations on how to improve communication and optimize the marketing strategy, with the main points of focus for the communication strategy as well as the topics that would be less impactful.
